SWM
ABEO icon

SHP Wealth Management’s Abeona Therapeutics ABEO Stock Holding History

SHP Wealth Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Hold
1,668
– – ﹤0.01% 968
2026
Q1 		$7.47K Hold
1,668
– – ﹤0.01% 976
2025
Q4 		$8.79K Buy
+1,668
New +$8.4K ﹤0.01% 865

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SHP Wealth Management's ABEO Position: Q2 2026 in Review

SHP Wealth Management held its Abeona Therapeutics (ABEO) position steady in Q2 2026 at 1,668 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #968.

SHP Wealth Management first reported a position in ABEO in Q4 2025 and has held it in 3 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • SHP Wealth Management held 1,668 shares of Abeona Therapeutics worth $10.3K as of Q2 2026.
  • SHP Wealth Management left its Abeona Therapeutics share count unchanged in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #968 holding.
  • SHP Wealth Management first reported a position in Abeona Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.